My only allowed post today at the other board was removed

New Post Public Reply Private Reply Replies (2) Message Board
BruceLake
762
My only allowed post today at the other board was removed due to it being a personal attack. What do they expect, that we extend personal compliments to management and all of their accomplices?

As I said to a friend today, I had to sell before the end of the year for tax reasons. I still hold some shares in another account, meaning that I'm officially allowed to bitch about the company and at the same time hope for a miracle.

Here is the deleted post:

Here is my one post of the day so I apologize in advance if it’s lengthy.

With regards to the previous R/S below is an email that I sent to Mr. Kenneth Koch back in April of this year. Obviously in the interim nothing has changed except giving us more reason to be upset, and justification for the added adjectives hurled to the pigs and criminals at management and those who support them. Yes, those who support them, are complicit, and are turning a blind eye to the scam that is going on, all for the almighty dollar! Yes, that includes Koch, Rubin, Sims, V-Stock Transfer, and let us not forget, all the “research facilities” that are supposedly conducting the “science” and profiting from those shareholders that have been victimized by the fraud that has been and continues to be committed.

We have every right to be pissed off. Nobody likes to be robbed. Thieves can end up in jail for stealing a chocolate bar, meanwhile for these vultures it’s business as usual. Feel free to forward this to everybody in management and anybody else that you can think of. Here are their emails:
KRKoch@mintz.com
mordechai.bignitz@owcpharma.com
stanley.hirsch@owcpharma.com
Sigal.Russo@owcpharma.com
alon.sinai@owcpharma.com
yehuda.baruch@owcpharma.com
jeffrey@jeffreyfriedland.com
rrubin@parkavenuegroup.us

For the sake of transparency, I’m glad that I held most of my shares until yesterday’s Record Date. Today I sold all of my shares in one of my accounts, but I am still entitled to vote. Not sure if it will make any difference but I plan to vote NO just as I did the last time. You may ask why sell now? For me the reason is very simple. My shares are worth much more dead than alive! The capital loss will offset my income tax on other significant capital gains.

Having said all of the above, it is my sincere wish that there is a miracle rebound so that many of you can recoup some of your losses. Given my record with timing that could very well happen.

Here is an email that was sent to OWCP’s lawyer and then no doubt forwarded to management. It’s already been shared with some of you. Remember my one-post limit, so I won’t be able to reply.

Good luck!

Quote:
Dear Mr. Kenneth Koch,

I am a shareholder of OWC Pharmaceutical Research Corp., trading as OWCP on the OTC exchange.

My understanding is that you and your firm are providing legal services to the company. I would assume that you are duly licensed to practice law. I say this with all due respect because for many years OWC Pharma engaged the services of a disbarred lawyer by the name of Richard Rubin. Mr. Rubin was referred to me by the company’s representatives Amir Uziel and Jeff Smurlick. I required the services of Mr. Rubin, specifically an opinion letter, in order to remove the restrictive legend from shares that I purchased as part of the company’s efforts in 2017 to raise funds. The shares were held by the company’s transfer agent, V-Stock Transfer. Transferring the shares to my trading account after the 6 month restrictive period proved to be impossible. This was mostly due to the added restrictions that V-Stock Transfer imposed, and partly due to the fact my broker RBC Investing, wasn’t about to compromise how they conduct their business. In order to facilitate the transfer, the afore-mentioned disbarred lawyer also had to provide an opinion letter to RBC. As it turns out this took almost a year to resolve, and not after the intervention of a consumer advocate. Meanwhile the company did absolutely nothing to help and facilitate the transfer, even though they promised that they would.

The SEC fraud case against Jeffrey Friedland made reference to a “disbarred lawyer”. I put two and two together and after some effort I was able to confirm that Richard Rubin had indeed been disbarred since 1995. On March 9, 2018 I sent an email (found below) to Yossi Dagan, the previous CFO advising him about my findings. Mr. Dagan acted surprised that all these years the company had been dealing with a disbarred lawyer. In a telephone conversation he said not to worry because they were now in the process of engaging the services of your law firm. When confronted, their standard reply to any of the well known and documented failures of the past, were to suggest that they were somehow also victims. They also went out of their way to say that the high caliber of the new management would not repeat the mistakes made in the past. Of course, Mr. Dagan glossed over the fact that some of the past management, including Mordechai Bignitz and Alon Sinai, had been in fact a constant since the inception of the company.

Speaking of management, apparently nothing has changed! From our vantage point as shareholders, it looks like the company has digressed with even more egregious mistakes being committed. Just over a year ago at the Wall Street Conference, Dr. Stanley Hirsch promised that given their new management team and considering what the company had already achieved so far, they would be “building massive .value for its shareholders”. He also went on to say that the company was looking for needed capital to further their research. What Dr. Hirsch should have said is that they were about to venture into a mission that was guaranteed to destroy shareholder value. As they say actions speak louder than words, and sometimes the best deal that one can make is the one that they don’t consummate. The $5 million loan agreement with Discovery guaranteed that they were headed to an ill advised mission that would keep on eroding any shareholder value that might have been left. One did not have to be a genius to arrive at this conclusion. To put it mildly, the agreement was toxic.

In an email that I sent to Yossi Dagan on May 10, 2018, I pointed out not only several errors in the loan agreement, but I also highlighted the “triggering events” within the agreement. Did anybody bother to read it? The most obvious triggering event that they should have addressed was Dr. Baruch and the possible legal issues that he might have to face. Sure enough, that’s exactly what came to pass. As a result, the company now was forced to pay Discovery bonus shares at a much greater discount. Anyone with any degree of competence should have picked up on this and dealt with it before the agreement was executed.

As a result of mismanagement, the company is now asking shareholders to support their proposal to implement a reverse split at some point before the end of the year, on terms yet to be defined but within a range of 1:2 to 1:500. Yes, Dr. Hirsch, is indeed asking shareholders to issue the company a blank cheque. The vast majority of shareholders have lost confidence in the current management group. History tells us that whatever it is that they will do, it will not be in the best interests of its long-suffering loyal shareholders. Their lack of communication with shareholders is so quiet that it is deafening. With regards to the proposed R/S the company wasted $7,500 for solicitation purposes to engage the services of a company and individual that was as clueless as a doorknob, who knows nothing about the company. In an effort to enhance their chances of getting approval to their R/S proposal the company also cooked up an ESOP that was backdated to February 5, 2019, strategically dated the day before the shareholders of record date of February 6, 2019. But it was not announced until some 5 weeks later in March. Not only was this a devious attempt at stacking the deck in their favour, it also brings into question legality and ethical issues.

Suffice it to say that the above sentiments are shared by an overwhelming number of shareholders. I would respectfully request that management re-thinks what their next moves are going to be. A significant shareholder made the comment that OWC has already fumbled the ball a few too many times in the end-zone. If not strictly illegal, they are certainly walking an ethical tightrope. All that one needs to do is to look at the circus atmosphere and the fraudulent pump and dump activity by the company’s past advisors. They may try to deny this all they want, but there should be zero doubt that management has been complicit to what was going on, or they were being grossly negligent, naive, or both. This is the history and legacy of the company. Going forward I trust that they will be very careful on how they proceed.

This email is being sent with the support of numerous shareholders that like me are heavily invested in the company and that are just as concerned with the direction the company is taking, and with their utter disdain towards us. The management has shown no respect for the fact that we the shareholders are the foundation of the company. I am directing this email to you because it seems the company has now made the decision to stop communicating with its shareholders, even when all we want to do is help. I kindly ask that you bring this email to management’s attention. Ultimately, we all want the company to succeed, to prove us wrong and to make us proud.

Respectfully,

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ecology Auto Parts Faces Class Action for Labor Code Violations

Updated Category News Views 4

Legal Battle Unfolds: Employees Take a Stand Step right up, folks, and get a load of the latest legal rumble pitting employees against the big machine of Ecology Auto Parts, Inc. Operating out of California, these auto-wrecking giants are now staring down the barrel of a class action lawsuit alleging they're skimping on labor law essentials. The lawsuit, which the folks...

Continue Reading
Suburban Propane Prepares for Fiscal 2026 Results Call

Updated Category News Views 2

Setting the Stage for Suburban Propane's Performance Review Buckle up, folks. Suburban Propane Partners, L.P. is gearing up to spill the beans about their Fiscal 2026 performance. They'll be talking numbers bright and early on November 12, 2026, at 9:00 AM Eastern Time, and whether you're dialing in or logging online, you might just catch a glimpse of where the propane...

Continue Reading
Limber Health's New Tool Set to Revolutionize Rehab

Updated Category News Views 33

A Shift in Rehab Therapy Alright, it's not every day you see a seismic shift in the world of rehab therapy. Limber Health just dropped the mic with their brand-new Recovery Forecast. Built on the heftiest risk-adjusted patient outcomes database in the game, this tool aims to replace those old-school, single-snapshot forecasts with a full 90-day predictive outlook. If you...

Continue Reading
Bose Grabs Skullcandy: A Bold Audio Acquisition Move

Updated Category News Views 7

Bose Broadens Horizons with Skullcandy Acquisition Well, here's a twist that rattles my morning coffee mug: Bose goes and buys Skullcandy. That’s right, the audio bigwig known for polished sound just snapped up the edgier, younger sibling in earbuds. Bose ain't just playing with sound anymore; they're grabbing lifestyle by the horns, hoping Skullcandy's flair will shake...

Continue Reading
LFG Charts New Path with Expanded Franchise Lineup

Updated Category News Views 0

A Unique Approach to Franchise Expansion LFG, or Limitless Franchise Growth if you prefer function over flair, is taking its expansion game to a different level. Based out of Scottsdale, these savvy folks have just beefed up their portfolio to nine diverse brand partners. You’d think they’re all about boosting numbers, right? But nah, they're so picky you'd think...

Continue Reading
CobbleStone & Chu Chua Tech: A Transformative Alliance

Updated Category News Views 0

Breaking Down the CobbleStone and Chu Chua Collaboration We’re in a tough, interconnected world where tech innovation is racing against the clock. So, when CobbleStone Software raises its hand to join forces with Chu Chua Technology Services LLP, it’s like a shot of adrenaline for anyone invested in North America’s tech wave. Let’s pause and dive right in because...

Continue Reading
NEXCOM Fortifies Academic Networks with NGFW Platforms

Updated Category News Views 1

Shielding Academic Networks in a Digital Era NEXCOM's stepping up to the plate to tackle the runaway train that is digital education. With classrooms going virtual and everything but the kitchen sink being plugged online, it's no wonder our beloved academic institutions are scrambling to hold the fort against cyber threats. Enter NEXCOM with their Next-Generation Firewall...

Continue Reading
CMCC Global Pioneers Tokenized Funds in El Salvador

Updated Category News Views 2

A Bold Move into Tokenization Tokenization: it's the buzzword that's got folks scratching their heads and bankers keeping an extra bottle of aspirin in their desk drawers. CMCC Global is diving headlong into this brave new world, rolling out two tokenized fund-of-funds right under El Salvador's fresh digital asset rules. Now that's gutsy. The Partners in Innovation...

Continue Reading
NJ Roads Spark Emmy Nod: A Public Affairs Win

Updated Category News Views 8

Our Infrastructure Gets Its Due Sometimes, the real unsung heroes aren’t the ones under bright lights but those toiling under the sun. “Our Infrastructure Matters,” a TV and web program taking a hard-nosed look at what's keeping our roads from crumbling under the weight of millions, just landed its first-ever New York Emmy nomination. Yep, you heard it right. No,...

Continue Reading
Third Eye Demands Fairer Terms for SkyAI Buyout

Updated Category News Views 5

Revamping the SkyAI Tender Offer Third Eye's backing of Bastion Trading's push for better terms in SkyAI's tender offer has put a spotlight on those crafty boardroom maneuvers. Investors aren't exactly thrilled with the crumbs being thrown their way, and it's about time someone held the cooks accountable. Getting What's Owed Here's the gist of it: Third Eye's not asking...

Continue Reading

Top 5 Most Recently Viewed Articles

An Inspiring Celebration Awaits: Explore LIGHT OF THE WORLD

Updated Category News Views 311

LIGHT OF THE WORLD Captivates Audiences The Story of Jesus Through Stunning Animation LIGHT OF THE WORLD, a remarkable animated feature from The Salvation Poem Project, has opened its doors to theaters nationwide, receiving an extraordinary response from viewers. The film has garnered an impressive 'A' Cinema Score, highlighting the enthusiasm with which audiences have...

Continue Reading
iliad SA Initiates Tender Offer for Bonds and Plans New Green Bonds

Updated Category News Views 129

iliad SA's Strategic Move: A Tender Offer on Existing Bonds iliad SA is actively making strides in the financial sector by launching a tender offer for its existing bonds set to mature in April 2025 and June 2026. The company's latest initiative aims at managing its debt profile while actively extending the maturity of its financial obligations. This significant action...

Continue Reading
Join the Class Action Against Coupang: Don’t Miss Out

Updated Category News Views 111

Important Class Action Against Coupang, Inc. Levi & Korsinsky, LLP is reaching out to investors of Coupang, Inc. to inform them about a significant class action lawsuit. This action is set to address the alleged securities fraud that affected many shareholders between specified dates. Class Definition and Legal Allegations This lawsuit aims to help investors recover...

Continue Reading
Incannex Healthcare Advances IHL-42X for Sleep Apnea Treatment

Updated Category News Views 157

Advancements in Sleep Apnea Treatment by Incannex Healthcare Incannex Healthcare Inc., recognized for its innovative approach in clinical-stage biopharmaceuticals, has made important strides in addressing obstructive sleep apnea (OSA) through its unique product, IHL-42X. This new oral combination medicine is specifically aimed at mitigating the interruptions in breathing...

Continue Reading
Sofinnova Partners Expands with New Partner Karl Naegler

Updated Category News Views 89

Sofinnova Partners Welcomes Karl Naegler as New Partner Sofinnova Partners, a leading venture capital firm in the life sciences field, is thrilled to announce that Karl Naegler has joined its team. With offices located in Paris, London, and Milan, this addition marks a strategic move to enhance Sofinnova's presence in Europe, particularly as it expands into Germany. Key...

Continue Reading